Abstract
Left heart bypass reduces the risk of ischemic complications during the repair of extensive thoracoabdominal aortic aneurysms. This prospective study compared the performance of the recently developed Nikkiso centrifugal pump with the well-established Bio-Medicus pump during left heart bypass for thoracoabdominal aortic aneurysm surgery. Thirty-five consecutive patients undergoing graft repair of extensive thoracoabdominal aortic aneurysms were prospectively assigned to have left heart bypass using either the Bio-Medicus (in the first 19 patients) or Nikkiso pump (in the next 16 patients). There were no significant differences in pump flow rates or patient hemodynamics between the two groups and there was no evidence of pump malfunction. All patients survived and none developed postoperative coagulopathy, myocardial infarction, or left heart failure. Paraparesis developed in 2 patients in the Nikkiso group (12.5%); there were no neurologic complications in the Bio-Medicus group (p = 0.202). One patient in the Bio-Medicus group developed renal failure (5.3%; p = 1.000 vs. Nikkiso group). Overall, no significant differences were found in the incidence of postoperative complications. Although a small series, this comparison demonstrates that the Nikkiso centrifugal pump is as effective and safe in providing left heart bypass during thoracoabdominal aortic aneurysm repair as the widely-used Bio-Medicus model.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call